1156180

Regeneron Pharmaceuticals Inc — FEI 1000521995

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 15, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tarrytown, NY (United States)

Additional Details

Sponsor, Contract Research Organization